The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases*
暂无分享,去创建一个
Kevin A. Kovalchik | A. Sette | E. Deutsch | B. Peters | E. Caron | J. Vizcaíno | Peter Kubiniok | Qing Ma | Jérôme D. Duquette | I. Mongrain | I. Sirois
[1] Sri H. Ramarathinam,et al. Response to Comment on “A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands” , 2019, Science Immunology.
[2] Lloyd M. Smith,et al. Comment on “A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands” , 2019, Science Immunology.
[3] G. Coukos,et al. Mass spectrometry–driven exploration reveals nuances of neoepitope-driven tumor rejection , 2019, JCI insight.
[4] D. Tscharke,et al. Quantification of epitope abundance reveals the effect of direct and cross-presentation on influenza CTL responses , 2019, Nature Communications.
[5] S. H. van der Burg,et al. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. , 2019, Molecular & cellular proteomics : MCP.
[6] H. Röst. Deep learning adds an extra dimension to peptide fragmentation , 2019, Nature Methods.
[7] Mathias Wilhelm,et al. Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning , 2019, Nature Methods.
[8] Jürgen Cox,et al. High-quality MS/MS spectrum prediction for data-dependent and data-independent acquisition data analysis , 2019, Nature Methods.
[9] Morten Nielsen,et al. IEDB-AR: immune epitope database—analysis resource in 2019 , 2019, Nucleic Acids Res..
[10] Sri H. Ramarathinam,et al. Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics , 2019, Nature Protocols.
[11] Karl Mechtler,et al. First Community-Wide, Comparative Cross-Linking Mass Spectrometry Study , 2019, Analytical chemistry.
[12] C. Perreault,et al. Discovery and characterization of actionable tumor antigens , 2019, Genome Medicine.
[13] H. Rammensee,et al. Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma , 2019, Genome Medicine.
[14] Y. Kamatani,et al. Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer. , 2019, Gastroenterology.
[15] Michael Wainberg,et al. Opportunities and challenges for transcriptome-wide association studies , 2019, Nature Genetics.
[16] David C Murray,et al. Acoustic Mist Ionization Platform for Direct and Contactless Ultrahigh-Throughput Mass Spectrometry Analysis of Liquid Samples. , 2019, Analytical chemistry.
[17] Sarah Lin,et al. TagGraph reveals vast protein modification landscapes from large tandem mass spectrometry data sets , 2019, Nature Biotechnology.
[18] A. Heck,et al. Pre-fractionation Extends but also Creates a Bias in the Detectable HLA Class Ι Ligandome , 2019, Journal of proteome research.
[19] Evan G. Williams,et al. Multi-omic measurements of heterogeneity in HeLa cells across laboratories , 2019, Nature Biotechnology.
[20] T. Chan,et al. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy , 2019, Nature Reviews Cancer.
[21] Bjoern Peters,et al. Most viral peptides displayed by class I MHC on infected cells are immunogenic , 2019, Proceedings of the National Academy of Sciences.
[22] Morten Nielsen,et al. MS‐Rescue: A Computational Pipeline to Increase the Quality and Yield of Immunopeptidomics Experiments , 2019, Proteomics.
[23] C. Brennan,et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types , 2019, Nature Genetics.
[24] T. Spector,et al. HLA alleles associated with risk of ankylosing spondylitis and rheumatoid arthritis influence the gut microbiome , 2019, bioRxiv.
[25] E. Petersdorf,et al. The MHC in the era of next-generation sequencing: Implications for bridging structure with function. , 2019, Human immunology.
[26] J. Lill,et al. MHC class I presented antigens from malignancies: A perspective on analytical characterization & immunogenicity. , 2019, Journal of proteomics.
[27] Martin Eisenacher,et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data , 2018, Nucleic Acids Res..
[28] S. Stevanović,et al. Purification and Identification of Naturally Presented MHC Class I and II Ligands. , 2019, Methods in molecular biology.
[29] M. Bassani-Sternberg,et al. High-Throughput, Fast, and Sensitive Immunopeptidomics Sample Processing for Mass Spectrometry. , 2019, Methods in molecular biology.
[30] Ton N Schumacher,et al. Cancer Neoantigens. , 2019, Annual review of immunology.
[31] Ngoc Hieu Tran,et al. Deep learning enables de novo peptide sequencing from data-independent-acquisition mass spectrometry , 2018, Nature Methods.
[32] J. Castle,et al. Actively personalized vaccination trial for newly diagnosed glioblastoma , 2018, Nature.
[33] Michele A. Busby,et al. Supplementary Materials for Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification , 2018 .
[34] P. Gendron,et al. Noncoding regions are the main source of targetable tumor-specific antigens , 2018, Science Translational Medicine.
[35] Eric A. Wilson,et al. Lost in the crowd: identifying targetable MHC class I neoepitopes for cancer immunotherapy , 2018, Expert review of proteomics.
[36] Lei Tang. Next-generation peptide sequencing , 2018, Nature Methods.
[37] J. Sidney,et al. Mapping the MHC Class I–Spliced Immunopeptidome of Cancer Cells , 2018, Cancer Immunology Research.
[38] Ruedi Aebersold,et al. Proteomics goes parallel , 2018, Nature Biotechnology.
[39] W. Xue,et al. Fine‐mapping of HLA class I and class II genes identified two independent novel variants associated with nasopharyngeal carcinoma susceptibility , 2018, Cancer medicine.
[40] J. A. López de Castro. How ERAP1 and ERAP2 Shape the Peptidomes of Disease-Associated MHC-I Proteins , 2018, Front. Immunol..
[41] Sri H. Ramarathinam,et al. A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands , 2018, Science Immunology.
[42] Edward M Marcotte,et al. Highly parallel single-molecule identification of proteins in zeptomole-scale mixtures , 2018, Nature Biotechnology.
[43] Hannah Carter,et al. Evolutionary Pressure against MHC Class II Binding Cancer Mutations , 2018, Cell.
[44] L. Kiemeney,et al. Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity , 2018, Nature Communications.
[45] Ilan Beer,et al. Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome* , 2018, Molecular & Cellular Proteomics.
[46] E. James,et al. The role of polymorphic ERAP1 in autoinflammatory disease , 2018, Bioscience reports.
[47] S. H. van der Burg,et al. Identification of non-mutated neoantigens presented by TAP-deficient tumors , 2018, The Journal of experimental medicine.
[48] Patrick G. A. Pedrioli,et al. A tissue-based draft map of the murine MHC class I immunopeptidome , 2018, Scientific Data.
[49] Sri H. Ramarathinam,et al. Employing proteomics in the study of antigen presentation: an update , 2018, Expert review of proteomics.
[50] J. Fellay,et al. Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines , 2018, Genome Medicine.
[51] David Gfeller,et al. Predicting Antigen Presentation—What Could We Learn From a Million Peptides? , 2018, Front. Immunol..
[52] Christian Gieger,et al. Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis , 2018, Nature Genetics.
[53] Johannes Griss,et al. Future Prospects of Spectral Clustering Approaches in Proteomics , 2018, Proteomics.
[54] S. Stevanović,et al. Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry , 2018, Immunology.
[55] Alex Rubinsteyn,et al. MHCflurry: Open-Source Class I MHC Binding Affinity Prediction. , 2018, Cell systems.
[56] A. Purcell,et al. Immunopeptidomics Special Issue , 2018, Proteomics.
[57] Juan Antonio Vizcaíno,et al. Minimal Information About an Immuno‐Peptidomics Experiment (MIAIPE) , 2018, Proteomics.
[58] D. Neri,et al. Membranal and Blood‐Soluble HLA Class II Peptidome Analyses Using Data‐Dependent and Independent Acquisition , 2018, Proteomics.
[59] J. Drijfhout,et al. Specific T Cell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell Surface , 2018, Proteomics.
[60] Mathieu Courcelles,et al. Comparison of the MHC I Immunopeptidome Repertoire of B‐Cell Lymphoblasts Using Two Isolation Methods , 2018, Proteomics.
[61] Sri H. Ramarathinam,et al. Identification of Native and Posttranslationally Modified HLA‐B*57:01‐Restricted HIV Envelope Derived Epitopes Using Immunoproteomics , 2018, Proteomics.
[62] Anthony W Purcell,et al. In Immunopeptidomics We Need a Sniper Instead of a Shotgun , 2018, Proteomics.
[63] Wout Bittremieux,et al. Fast open modification spectral library searching through approximate nearest neighbor indexing , 2018, bioRxiv.
[64] Kazuhiko Yamamoto,et al. Deep whole-genome sequencing reveals recent selection signatures linked to evolution and disease risk of Japanese , 2018, Nature Communications.
[65] P. Kelly,et al. The Cancer Immunotherapy Revolution. , 2018, Science.
[66] Jedd D. Wolchok,et al. Cancer immunotherapy using checkpoint blockade , 2018, Science.
[67] Omkar U. Kawalekar,et al. CAR T cell immunotherapy for human cancer , 2018, Science.
[68] Ö. Türeci,et al. Personalized vaccines for cancer immunotherapy , 2018, Science.
[69] A. Zhernakova,et al. The importance of cohort studies in the post-GWAS era , 2018, Nature Genetics.
[70] Catherine J. Wu,et al. Towards personalized, tumour-specific, therapeutic vaccines for cancer , 2017, Nature Reviews Immunology.
[71] Ophir Vermesh,et al. Toward achieving precision health , 2018, Science Translational Medicine.
[72] Jennifer G. Abelin,et al. The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction , 2018, Proteomics.
[73] M. Berger,et al. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy , 2018, Science.
[74] J. Yewdell,et al. Enhancing responses to cancer immunotherapy , 2018, Science.
[75] Calliope A. Dendrou,et al. HLA variation and disease , 2018, Nature Reviews Immunology.
[76] Nuno A. Fonseca,et al. Expression Atlas: gene and protein expression across multiple studies and organisms , 2017, Nucleic Acids Res..
[77] G. Coukos,et al. The C-terminal extension landscape of naturally presented HLA-I ligands , 2017, Proceedings of the National Academy of Sciences.
[78] Roman A. Zubarev,et al. The SysteMHC Atlas project , 2017, Nucleic Acids Res..
[79] Michal Bassani-Sternberg,et al. Mass Spectrometry Based Immunopeptidomics for the Discovery of Cancer Neoantigens. , 2018, Methods in molecular biology.
[80] C. Perreault,et al. Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy , 2018, Cellular and Molecular Life Sciences.
[81] Juliane Liepe,et al. Post-translational peptide splicing and T cell response , 2017 .
[82] A. Krackhardt,et al. Tools to define the melanoma‐associated immunopeptidome , 2017, Immunology.
[83] Karl-Heinz Jöckel,et al. Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility , 2017, Nature Communications.
[84] T. Ideker,et al. MHC-I Genotype Restricts the Oncogenic Mutational Landscape , 2017, Cell.
[85] Hui Zhang. Acoustic dispensing-mass spectrometry: the next high throughput bioanalytical platform for early drug discovery. , 2017, Bioanalysis.
[86] Oliver Kohlbacher,et al. The immunopeptidomic landscape of ovarian carcinomas , 2017, Proceedings of the National Academy of Sciences.
[87] M. Nielsen,et al. Computational Tools for the Identification and Interpretation of Sequence Motifs in Immunopeptidomes , 2017, bioRxiv.
[88] Michael J. T. Stubbington,et al. The Human Cell Atlas: from vision to reality , 2017, Nature.
[89] D. Ritz,et al. Data‐Independent Acquisition of HLA Class I Peptidomes on the Q Exactive Mass Spectrometer Platform , 2017, Proteomics.
[90] Ruedi Aebersold,et al. A Case for a Human Immuno‐Peptidome Project Consortium , 2017, Immunity.
[91] P. Kloetzel,et al. Multi-level Strategy for Identifying Proteasome-Catalyzed Spliced Epitopes Targeted by CD8+ T Cells during Bacterial Infection. , 2017, Cell reports.
[92] Ludmila V. Danilova,et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.
[93] S. Mallal,et al. T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.
[94] G. McVean,et al. Structural and regulatory diversity shape HLA-C protein expression levels , 2017, Nature Communications.
[95] P. Parham,et al. Distinguishing functional polymorphism from random variation in the sequences of >10,000 HLA-A, -B and -C alleles , 2017, PLoS genetics.
[96] Morten Nielsen,et al. The Effect of a Tropical Climate on Available Nutrient Resources to Springs in Ophiolite-Hosted, Deep Biosphere Ecosystems in the Philippines , 2017, Front. Microbiol..
[97] Fabian J Theis,et al. The Human Cell Atlas , 2017, bioRxiv.
[98] S. Mallal,et al. T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.
[99] Cisca Wijmenga,et al. The MHC locus and genetic susceptibility to autoimmune and infectious diseases , 2017, Genome Biology.
[100] Sri H. Ramarathinam,et al. MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape , 2017, Nature Structural &Molecular Biology.
[101] Alexey I Nesvizhskii,et al. MSFragger: ultrafast and comprehensive peptide identification in shotgun proteomics , 2017, Nature Methods.
[102] I. Hellmann,et al. Comparative Analysis of Single-Cell RNA Sequencing Methods , 2016, bioRxiv.
[103] J. Shabanowitz,et al. Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma. , 2017, Journal of proteome research.
[104] Albert J R Heck,et al. Arginine (Di)methylated Human Leukocyte Antigen Class I Peptides Are Favorably Presented by HLA-B*07. , 2017, Journal of proteome research.
[105] Juan Antonio Vizcaíno,et al. The ProteomeXchange consortium in 2017: supporting the cultural change in proteomics public data deposition , 2016, Nucleic Acids Res..
[106] Valentine Svensson,et al. Power Analysis of Single Cell RNA-Sequencing Experiments , 2016, Nature Methods.
[107] Erika Check Hayden. The rise and fall and rise again of 23andMe , 2017, Nature.
[108] M. Mann,et al. Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry , 2016, Nature Communications.
[109] F. Pazos,et al. A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens* , 2016, Molecular & Cellular Proteomics.
[110] P. Kloetzel,et al. A large fraction of HLA class I ligands are proteasome-generated spliced peptides , 2016, Science.
[111] M. D. Chamberlain,et al. Digital Microfluidics for Immunoprecipitation. , 2016, Analytical chemistry.
[112] Ruedi Aebersold,et al. Mass-spectrometric exploration of proteome structure and function , 2016, Nature.
[113] Brett Larsen,et al. Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry , 2016, bioRxiv.
[114] Ruedi Aebersold,et al. Proteome-wide association studies identify biochemical modules associated with a wing-size phenotype in Drosophila melanogaster , 2016, Nature Communications.
[115] N. Eriksson,et al. Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections , 2016, Nature Communications.
[116] William Stafford Noble,et al. Fast and Accurate Protein False Discovery Rates on Large-Scale Proteomics Data Sets with Percolator 3.0 , 2016, Journal of The American Society for Mass Spectrometry.
[117] George Coukos,et al. Mass spectrometry-based antigen discovery for cancer immunotherapy. , 2016, Current opinion in immunology.
[118] M. Beksac,et al. HLA polymorphism and risk of multiple myeloma , 2016, Leukemia.
[119] J. Tardif,et al. Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation , 2016, Circulation. Cardiovascular genetics.
[120] Johannes Griss,et al. Recognizing millions of consistently unidentified spectra across hundreds of shotgun proteomics datasets , 2016, Nature Methods.
[121] Steven P. Gygi,et al. Defining the consequences of genetic variation on a proteome-wide scale , 2016, Nature.
[122] Evan G. Williams,et al. Systems proteomics of liver mitochondria function , 2016, Science.
[123] D. Tscharke,et al. Immunology by numbers: quantitation of antigen presentation completes the quantitative milieu of systems immunology! , 2016, Current opinion in immunology.
[124] L. Santambrogio,et al. The melting pot of the MHC II peptidome. , 2016, Current opinion in immunology.
[125] J. McPherson,et al. Coming of age: ten years of next-generation sequencing technologies , 2016, Nature Reviews Genetics.
[126] E. Unanue,et al. Variations in MHC Class II Antigen Processing and Presentation in Health and Disease. , 2016, Annual review of immunology.
[127] A. Bouchie,et al. Nature Biotechnology's academic spinouts of 2015 , 2016, Nature Biotechnology.
[128] J. Banchereau,et al. The Human Vaccines Project: A roadmap for cancer vaccine development , 2016, Science Translational Medicine.
[129] T. Kim,et al. HLA-C*01 is a Risk Factor for Crohn's Disease , 2016, Inflammatory bowel diseases.
[130] D. Harlan,et al. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion , 2016, Science.
[131] Johannes Griss,et al. Spectral library searching in proteomics , 2016, Proteomics.
[132] Alessandro Sette,et al. Deciphering the human antigenome , 2016, Expert review of vaccines.
[133] Bjarni V. Halldórsson,et al. HLA class II sequence variants influence tuberculosis risk in populations of European ancestry , 2016, Nature Genetics.
[134] Joshua E Elias,et al. Application of de Novo Sequencing to Large-Scale Complex Proteomics Data Sets. , 2016, Journal of proteome research.
[135] Morten Nielsen,et al. Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove , 2016, eLife.
[136] Nathan P Croft,et al. Quantifying epitope presentation using mass spectrometry. , 2015, Molecular immunology.
[137] D. Tscharke,et al. Sizing up the key determinants of the CD8+ T cell response , 2015, Nature Reviews Immunology.
[138] Etienne Caron,et al. Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry* , 2015, Molecular & Cellular Proteomics.
[139] J. D. Watson,et al. Human Genome Project: Twenty-five years of big biology , 2015, Nature.
[140] Mark Cobbold,et al. Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry , 2015, Nature Protocols.
[141] Alexandre M J J Bonvin,et al. Extended O-GlcNAc on HLA Class-I-Bound Peptides. , 2015, Journal of the American Chemical Society.
[142] Buhm Han,et al. Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk , 2015, Nature Genetics.
[143] Alessandro Sette,et al. An open-source computational and data resource to analyze digital maps of immunopeptidomes , 2015, eLife.
[144] Bert Vogelstein,et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.
[145] C. Perreault,et al. The nature of self for T cells-a systems-level perspective. , 2015, Current opinion in immunology.
[146] E. Mardis,et al. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells , 2015, Science.
[147] M. Kieny,et al. Building the Human Vaccines Project: strategic management recommendations and summary report of the 15–16 July 2014 business workshop , 2015, Expert review of vaccines.
[148] J. Tardif,et al. Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib , 2015, Circulation. Cardiovascular genetics.
[149] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[150] M. Daly,et al. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci , 2015, Nature Communications.
[151] Å. Lernmark,et al. Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA. , 2015, The Journal of clinical investigation.
[152] Z. Modrušan,et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing , 2014, Nature.
[153] Maxim N. Artyomov,et al. Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens , 2014, Nature.
[154] Edward M. Marcotte,et al. A Theoretical Justification for Single Molecule Peptide Sequencing , 2014, bioRxiv.
[155] Jeroen Krijgsveld,et al. Ultrasensitive proteome analysis using paramagnetic bead technology , 2014, Molecular systems biology.
[156] Pierre Thibault,et al. Efficient sample processing for proteomics applications—Are we there yet? , 2014, Molecular systems biology.
[157] Peter A van Veelen,et al. Accurate quantitation of MHC-bound peptides by application of isotopically labeled peptide MHC complexes. , 2014, Journal of proteomics.
[158] Eric W. Deutsch,et al. A repository of assays to quantify 10,000 human proteins by SWATH-MS , 2014, Scientific Data.
[159] Evan G. Williams,et al. Multilayered Genetic and Omics Dissection of Mitochondrial Activity in a Mouse Reference Population , 2014, Cell.
[160] W. Koff,et al. Toward a Human Vaccines Project , 2014, Nature Immunology.
[161] B. Kuster,et al. Mass-spectrometry-based draft of the human proteome , 2014, Nature.
[162] Nathan D. Price,et al. Demystifying Disease, Democratizing Health Care , 2014, Science Translational Medicine.
[163] Andrew R. Jones,et al. ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination , 2014, Nature Biotechnology.
[164] A. Ramos-Fernández,et al. Increased Diversity of the HLA-B40 Ligandome by the Presentation of Peptides Phosphorylated at Their Main Anchor Residue. , 2014, Molecular & cellular proteomics : MCP.
[165] Peggy Hall,et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..
[166] Jennifer Couzin-Frankel,et al. Breakthrough of the year 2013. Cancer immunotherapy. , 2013, Science.
[167] S. Factor,et al. Association of Parkinson disease with structural and regulatory variants in the HLA region. , 2013, American journal of human genetics.
[168] Jennifer G. Abelin,et al. MHC Class I–Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia , 2013, Science Translational Medicine.
[169] J. Knight,et al. Major histocompatibility complex genomics and human disease. , 2013, Annual review of genomics and human genetics.
[170] P. Jensen,et al. Structural Characteristics of HLA-DQ that May Impact DM Editing and Susceptibility to Type-1 Diabetes , 2013, Front. Immunol..
[171] Amber L. Couzens,et al. The CRAPome: a Contaminant Repository for Affinity Purification Mass Spectrometry Data , 2013, Nature Methods.
[172] Philip R. Johnson,et al. Accelerating Next-Generation Vaccine Development for Global Disease Prevention , 2013, Science.
[173] Eric W. Deutsch,et al. Combining Results of Multiple Search Engines in Proteomics* , 2013, Molecular & Cellular Proteomics.
[174] Alessandro Sette,et al. Discovering naturally processed antigenic determinants that confer protective T cell immunity. , 2013, The Journal of clinical investigation.
[175] David Heckerman,et al. Influence of HLA-C Expression Level on HIV Control , 2013 .
[176] Johannes Griss,et al. PRIDE Cluster: building a consensus of proteomics data , 2013, Nature Methods.
[177] John A. Todd,et al. Proteome-Wide Analysis of Disease-Associated SNPs That Show Allele-Specific Transcription Factor Binding , 2012, PLoS genetics.
[178] Bas van Breukelen,et al. Current challenges in software solutions for mass spectrometry-based quantitative proteomics , 2012, Amino Acids.
[179] T. Gajewski,et al. Cancer immunotherapy , 2012, Molecular oncology.
[180] K. Lundin,et al. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease. , 2012, Gastroenterology.
[181] Ming D. Li,et al. Large-scale genome-wide association study of Asian population reveals genetic factors in FRMD4A and other loci influencing smoking initiation and nicotine dependence , 2011, Human Genetics.
[182] Morten Nielsen,et al. NetMHCcons: a consensus method for the major histocompatibility complex class I predictions , 2011, Immunogenetics.
[183] Sébastien Lemieux,et al. The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation , 2011, Molecular systems biology.
[184] Natalie I. Tasman,et al. iProphet: Multi-level Integrative Analysis of Shotgun Proteomic Data Improves Peptide and Protein Identification Rates and Error Estimates* , 2011, Molecular & Cellular Proteomics.
[185] Arie Admon,et al. The Human Immunopeptidome Project, a Suggestion for yet another Postgenome Next Big Thing , 2011, Molecular & Cellular Proteomics.
[186] L. Hood,et al. Predictive, personalized, preventive, participatory (P4) cancer medicine , 2011, Nature Reviews Clinical Oncology.
[187] R. Aebersold,et al. Generating and navigating proteome maps using mass spectrometry , 2010, Nature Reviews Molecular Cell Biology.
[188] Charles Auffray,et al. Predictive, preventive, personalized and participatory medicine: back to the future , 2010, Genome Medicine.
[189] E. Bergseng,et al. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation , 2009, Nature Immunology.
[190] Christoph H Borchers,et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.
[191] Robert E. Kearney,et al. A HUPO test sample study reveals common problems in mass spectrometry-based proteomics , 2009, Nature Methods.
[192] J. Murray,et al. The role of HLA-DQ8 β57 polymorphism in the anti-gluten T-cell response in coeliac disease , 2008, Nature.
[193] Ruedi Aebersold,et al. Building consensus spectral libraries for peptide identification in proteomics , 2008, Nature Methods.
[194] J. Shabanowitz,et al. Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for presentation of transformed self , 2008, Nature Immunology.
[195] Elaine Holmes,et al. The metabolome-wide association study: a new look at human disease risk factors. , 2008, Journal of proteome research.
[196] Ian J. Brown,et al. Human metabolic phenotype diversity and its association with diet and blood pressure , 2008, Nature.
[197] Donald Kennedy,et al. Breakthrough of the Year , 2007, Science.
[198] O. Lund,et al. NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence , 2007, PloS one.
[199] James McCluskey,et al. More than one reason to rethink the use of peptides in vaccine design , 2007, Nature Reviews Drug Discovery.
[200] V. Engelhard. The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes. , 2007, International journal of mass spectrometry.
[201] Anne M Evans,et al. Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy , 2006, Proceedings of the National Academy of Sciences.
[202] M. Mann,et al. Parts per Million Mass Accuracy on an Orbitrap Mass Spectrometer via Lock Mass Injection into a C-trap*S , 2005, Molecular & Cellular Proteomics.
[203] H. Rammensee,et al. Glycan side chains on naturally presented MHC class II ligands. , 2005, Journal of mass spectrometry : JMS.
[204] Sorin Istrail,et al. Comparative immunopeptidomics of humans and their pathogens. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[205] Muthuraman Sathiamurthy,et al. Toward a Definition of Self: Proteomic Evaluation of the Class I Peptide Repertoire1 , 2004, The Journal of Immunology.
[206] I. Messaoudi,et al. Direct Link Between mhc Polymorphism, T Cell Avidity, and Diversity in Immune Defense , 2002, Science.
[207] Hiroshi Sato,et al. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction , 2002, Nature Genetics.
[208] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[209] F. Marincola,et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[210] L. Fugger,et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease , 1998, Nature Medicine.
[211] J. Shabanowitz,et al. The Immunodominant Antigen of an Ultraviolet-induced Regressor Tumor Is Generated by a Somatic Point Mutation in the DEAD Box Helicase p68 , 1997, The Journal of experimental medicine.
[212] J. Goedert,et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.
[213] S. Nathenson,et al. Methods to study peptides associated with MHC class I molecules. , 1994, Current opinion in immunology.
[214] V. Engelhard,et al. Structure of peptides associated with class I and class II MHC molecules. , 1994, Annual review of immunology.
[215] R. Henderson,et al. Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[216] R. Henderson,et al. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. , 1993, Journal of immunology.
[217] R. Henderson,et al. Mass spectrometric analysis of peptides associated with the human class I MHC molecules HLA-A2.1 and HLA-B7 and identification of structural features that determine binding. , 1993, Chemical Immunology.
[218] R. Henderson,et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.
[219] R. Henderson,et al. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. , 1992, Science.
[220] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[221] Hans-Georg Rammensee,et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.
[222] D. Mccormick. Sequence the Human Genome , 1986, Bio/Technology.